Welcome to Dr John Chaplin Head and Neck Surgeon

What's new

Latest news

Head and Neck Surgery- Auckland

Your Surgeon

Dr John Chaplin is an experienced,  high volume head and neck surgeon with  an international pedigree and reputation. John is an expert in the management of thyroid nodules and particularly thyroid cancer including thyroid cancer that has metastasised to neck lymph nodes. John also has expertise in diagnosing and managing salivary gland tumours and swellings . He is highly skilled in managing the facial nerve in parotid tumours and particularly in cancers involving the parotid gland. John has just completed co-authoring a book chapter on the management of metastatic and advanced cutaneous malignancy to the parotid gland that is due for publication in late 2019. He is a surgical leader in neck dissection  and performs neck dissection procedures weekly for management tongue cancer, HPV and non HPV related throat cancer, larynx cancer and skin cancer that has metastasised to neck lymph nodes. Dr John Chaplin has 20+ years experience in private and public hospital in head and neck surgery and is an integral member of the Auckland Regional Head and Neck Team. John has trained over 20 international fellows in head and neck surgery and microvascular reconstruction and he  is the highest volume head and neck reconstructive surgeon in the country. John can see patients with neck lumps urgently. Call (09) 6311948 or click this link


One Stop Neck Lump Clinic

John Chaplin performs neck lymph node  and neck lump investigations with office based ultrasound scan and fine needle aspiration (FNA) biopsy at his One Stop Neck Lump Clinic based at Mauranui Clinic in Epsom, Auckland.

Examination and Endoscopy

At these appointments a full expert head and neck examination is performed and this includes flexible endoscopy of the upper airway. This allows a comprehensive assessment of potential tumour primary sites that may lead to neck lumps. This is particularly relevant in the current HPV related oropharyngeal cancer era, where it is recognised that there is an increase in HPV related tonsil and base of tongue throat cancer that goes against the decline in other cancers seen.

Neck and Thyroid Ultrasound

Ultrasound is performed at the time and the site,  number and size of the lump or lumps is noted. In addition, the echogenicity, shape, margin, vascularity and calcifications are reported upon. These  features are compared against risk based scoring systems particularly with respect to thyroid nodules to determine whether FNA biopsy is indicated.

Neck Lump FNA Biopsy

If FNA is indicated it will be performed under ultrasound guidance as this allows accurate placement of the needle into the tissue likely to offer the highest yield of cellular material and therefore a diagnosis. The material is processed urgently and an accurate answer is available within 24-48 hours. A follow up appointment will be arranged to discuss the results.

CT Scanning

CT scanning is available on site at Mauranui Clinic with Ascot@Mauranui scanning allowing full contrast enhanced scanning appropriate for assessment of primary site and regional nodal assessment as well as assessment of distant sites like lungs.

Services offered at our “One Stop Neck Lump Clinic.”

Mauranui Clinic 86 Gt South Road Epsom

Urgent appointments available here

Specialist assessment.

At our Neck Lump Clinic you will  not be assessed by  a recently qualified, recently trained surgeon who has a limited degree of experience. You will be seen by Dr John Chaplin, a highly experienced head and neck surgeon who is trained to recognise the nuances of neck lump presentation.  Examinations are thorough and once investigations are performed, at the same appointment setting, it is usual for an experienced surgeon to have a working diagnosis in a very short time.

The treating surgeon  can then usually give you a very accurate outline of what further investigation and treatment would involve. The level of high volume surgery and vast experience of the specialist makes this a far more comprehensive interaction than may be available elsewhere. The patient will benefit from:


Office Based Neck Ultrasound Examination

Any patient who attends our One Stop Neck Lump Clinic will undergo an office based ultrasound scan using a General Electric Logiq E scanner that, despite being a small machine, has fantastic resolution and produces some of the best images I have seen. Many years of looking at ultrasound images of neck lumps every day along with the insight that may years of performing complex open neck surgery has given me unparalleled intuition as to what might be significant or not. I am not necessarily influenced by radiology or pathology opinions that come from personnel that spread there skills among other anatomical and pathological areas as those who work for other neck lump clinic services may be.


Fine Needle Aspiration Biopsy (FNA)

A safe and accurate technique to investigate all lumps in the neck including nodules in the thyroid gland tumours in the salivary glands and all pathology in neck lymph nodes. A fine needle is passed into the neck lump under ultrasound guidance to ensure accurate placement into the tissue most likely to yield diagnostic material. The needle in then massaged in and out of the neck lump to milk cells up into the needle shaft. The cells are then either smeared onto a glass slide and sprayed with fixative or washed into cell preserving solution and sent to the lab. Usually the results are available in 24-48 hours and Dr Chaplin will contact you with this results.

CT scanning

Full contrast enhanced CT scanning is available onsite at Mauranui Clinic, 86 Great South Road Epsom Auckland. Where appropriate a scan will be arranged at the time of the original appointment reducing the inconvenience of another  appointment and speeding up the diagnostic process significantly.


Urgent Neck Lump Appointments Available

Call  096311948


When Should I See A Neck Lump Specialist?

All lumps in the neck must have a diagnosis! A specialist review at our One Stop Neck Lump Clinic at 86 Mauranui Clinic in Epsom, Auckland will allow a diagnosis and management plan in the earliest possible time. Call Auckland 09 6311948 for or click on this link for an urgent appointment

Neck Lumps occur at different ages and in different areas of the neck and these factors can help lead to an early diagnosis. In younger adults and children lumps in the neck are usually either inflammatory or congenital in origin whereas in older adults a much higher index of suspicion for cancer must be maintained. The neck is divided into several regions: 1. Anterior neck; 2. Lateral neck; 3. Posterior neck; 4. Angle of the jaw; 5. Submandibular region. The anterior  neck is divided at the level of the hyoid bone into a. suprahyoid and b. infra hyoid regions. The lateral neck is further divided into a. The carotid sheath and b. The posterior triangle.

Posterior Neck Lumps

The posterior neck contains very few structures of importance and skin cancer metastasising to occipital and post auricular lymph nodes are the only significant malignancies that present in this region. Other lumps include lipomas and benign lymph node swellings.

Anterior Neck Lumps

Infrahyoid masses will be mostly thyroid in origin see Thyroid Surgery. Nearly all thyroglossal duct cysts are below the hyoid, slightly left of midline, and seen in young people. Pretracheal nodes that are caused by metastatic laryngeal or thyroid tumours can also present in this region . Suprahyoid masses may be thyroglossal but are more likely to be submental lymph nodes involved by inflammation or malignancy from the skin or oral cavity, particularly the floor of mouth. Dermoids are rare developmental inclusion cysts that form in the midline during embryonic development but often do not manifest until later in life. Thyroid tissue can arrest anywhere along the thyroglossal tract and can present in the submental region.

Lateral Neck Lumps

Lateral neck masses are more complex. They most commonly present in the carotid sheath in association with the carotid artery or jugular vein but they can also appear in the posterior triangle.
Solid lesions in the lateral neck are either nodal (inflammatory or metastatic malignancy) or they are rare tumours like carotid body tumours, neurogenic tumours associated with many of the nerves in the neck or rarely they can be malignant sarcomas of the deep neck tissues. Cystic lesions may be congenital branchial cleft cysts or lymphatic/vascular malformations. However they may also be cystic malignant nodes. These are notoriously difficult to diagnose and needle biopsies are often non- diagnostic.
Cystic nodal metastases are frequently confused with benign branchial cleft cysts and a careful history of upper aerodigestive tract symptoms is important to elicit.particularly in the era of HPV related Oropharyngeal cancer. Thyroid cancers may also appear as cystic lymph nodes in the lateral neck
Lesions in the skin and subcutaneous tissues are usually benign but skin cancers and melanoma can occur as cutaneous nodules.
Nodal lesions in the posterior triangle and supraclavicular area are less common. Metastases to this area either come from skin lesions in the posterior scalp or  from nasopharyngeal carcinoma, most frequently seen in Asian patients. Typically TB can affect lymph nodes in this area. Atypical TB in children tends to affect level I nodes in the submandibular area.

Submandibular Neck Lumps

Lumps in the submandibular area are usually related to the submandibular gland. Obstruction of the duct by stones or sludge typically presents as painful swelling associated with eating or even with the thought of food. The swelling will generally resolve over a period unless an ascending infection develops. Sometimes the stone can be felt in the duct in the floor of the mouth. Massaging the gland rather than producing a good flow of clear saliva often produces a small amount of turbid saliva or none at all. Submandibular salivary tumours present as painless progressive swellings. About 50% are malignant. See Salivary Gland Surgery.

Lymph node metastases to this area are either from lip or anterior facial skin cancers or from tumours on the oral tongue, floor of mouth or buccal mucosa.

Lumps at the Angle of the Jaw

Parotid swellings, that occur in the preauricular area, in the tail (which is often difficult to separate from the upper neck) or in the deep lobe, are usually neoplasms. Most tumours are benign but NZ has a high incidence of metastatic skin cancer to nodes in the parotid and our most common parotid malignancy is metastatic SCC. See Salivary Gland Surgery
Congenital cysts can occur in this region and they originate from the first branchial arch.


If you have concern regarding a neck lump call our One Stop Neck Lump Clinic on Auckland 09 6311948



Thyroid Nodules

What are Thyroid Nodules?

A thyroid nodule is a radiologically distinct entity that appears different to the surrounding thyroid parenchyma usually on ultrasound scan. Nodules can be solid, cystic or a combination of these. Cystic portions are anechoic on ultrasound and they appear black with through transmission of ultrasound appearing bright at the far edge of the cyst whereas solid portions have varying degrees of echogenicity making them appear different shades of grey through to black.

What Causes Thyroid Nodules?

Firstly, thyroid nodules are very common appearing in 3-5% of the population as a palpable lump and in 20-70% of the population on neck ultrasound. They are more common in women and with increasing age. The vast majority of thyroid nodules are benign ( non cancerous) but up to 5% of thyroid nodules will be thyroid cancers. Benign nodules are more common in areas of iodine deficiency,  in patients with a background of autoimmune (Hashimoto’s) thyroiditis and also in those who have had radiation exposure to the thyroid gland. Thyroid nodules occur in families indicating that, at least in some cases, there is a genetic basis to their development. Studies have demonstrated up to 25% of benign nodules have mutually exclusive genetic mutations that are different to those found in papillary thyroid cancers. The mutations responsible for development of thyroid cancers include: BRAF, RET and NTRK-1  in PTC;   Pax8-PPARgamma and RAS group mutations in FTC; TP53 in ATC : and RET mutations in MTC. the RET mutations in PTC are seen most often in children that have been exposed to radiation.

Symptoms of Thyroid Nodules.

Small nodules are often asymptomatic but as they increase in size they can cause compressive symptoms and patients will complain of the sensation of pressure on the trachea (windpipe), the sensation of a lump associated with swallowing and even a gagging sensation. these symptoms are usually associated with nodules over 3 cm in size. As the nodules become even larger and particularly in the setting of multiple nodules as in a multi nodular goitre (MNG), patients may  experience further compression that can lead to shortness of breath, cough and wheeze. The voice can frequently be altered in this situation and patients can also have pain  if there is bleeding into thyroid nodules. Bleeding into nodules is not uncommon and patients present with the sudden onset of a thyroid lump and discomfort that settles over a few days as the nodule gets smaller. Occasionally thyroid nodules can be metabolically overactive and a patient will present with symptoms of hyperthyroidism or thyrotoxicosis including tremor, tachycardia, sweating, anxiety, heat intolerance and agitation. As lymphocytic thyroiditis is a precursor for thyroid nodularity patients with thyroid nodules may also have symptoms of hypothyroidism.

How are Thyroid Nodules Investigated?

The important primary investigations for a patient with a known or suspected thyroid nodule include and ultrasound scan and thyroid function tests.

Ultrasound Scan

Ultrasound is a highly accurate investigation for looking at the details of a nodule and for assessing its risk for being a cancer. There are several scoring systems that have been devised to identify the degree of risk and which nodules should be recommended for Fine Needle aspiration (FNA) biopsy, observation  or no follow up. The one in wide use in Auckland is The TIRADS system from the American College of Radiology (ACR). This system scores thyroid nodules based on shape, margin, echogenicity, density , and whether there are calcifications within the nodules. Scores range from TR1 (benign) through TR6 (biopsy proven malignancy) and then size is used to make recommendations regarding FNA. An online TIRADS Calculator makes this an easy system to utilise. A nodule with a TIRADS score of TR5 that is over 1cm in size should have a FNA similarly a nodule that Scores TR3 should only have FNA if it is >2.5cm and should be followed if it is >1.5cm.

A TIRADS TR5 nodule that is solid, hypoechoic, Taller than wide, Has an irregular margin and contains punctate echogenic foci (PEF) it is over 1 cm in size and biopsy is recommended.

A TIRADS TR5 nodule that is solid, hypoechoic, Taller than wide, Has an irregular margin and contains punctate echogenic foci (PEF) it is over 1 cm in size and biopsy is recommended.

TIRADS TR3 nodule that is isoechoic, spongiform, wider than tall shape, has an irregular margin and no calcifications. As it is 1.5 observation is recommended.

TIRADS TR3 nodule that is isoechoic, spongiform, wider than tall shape, has an irregular margin and no calcifications. As it is >1.5cm (in vertical dimension not shown)  observation is recommended.

Fine Needle Aspiration (FNA) Biopsy

FNA is an important second line investigation in the management of thyroid nodules. As mentioned above, the ultrasound study can allow risk stratification of thyroid nodules and identify which nodules should undergo biopsy. There are also a variety of risk assessment tools for FNA around the world and here in Auckland we use The Bethesda System developed by the NIH and adopted by the American Thyroid Association. Again, there are six categories with Bethesda 1 being non diagnostic and Bethesda 6 diagnostic of malignancy. See table 1

Table 1. The Bethesda System for thyroid cytopathology with associated risk of malignancy per category in 2009 and 2017.

Table 1. The Bethesda System for thyroid cytopathology with associated risk of malignancy per category in 2009 and 2017.

There is a risk of malignancy associated with each category as shown in table 1 and this has changed over time with increased data and changes in diagnostic categories. I find in my own practice that FNA performed under ultrasound guidance gives a much higher yield of diagnostic aspirates and I perform nearly all FNA biopsies under ultrasound guidance.

Thyroid Function Tests

Thyroid function tests are necessary when investigating thyroid nodules. It is important to know whether a nodule is overactive because if so, it would be extremely unlikely to be malignant and also thyroid surgery is an appropriate way of managing a toxic nodule. It is important also to know whether a patient is hypothyroid as the risk of malignancy is higher in patients with a background of lymphocytic (hashimotos) thyroiditis.

Go to Treatment of thyroid Nodules and Cancer

Types of thyroid cancer

There are several different types of thyroid cancers and they are broadly broken into categories based on the cells that they originate from and their behaviour. Most thyroid cancers are low grade, differentiated thyroid cancers that originate from thyroid follicle cells, generally behave in an indolent fashion and have very high rates of survival. At the other end of the spectrum are anaplastic thyroid cancers that are among the most aggressive human cancers, have a rapidly progressive disease course and have  rates of disease specific death approaching 100%. In between these are a group of poorly differentiated cancers that also originate from thyroid follicular cells, occur in older patients and do worse than differentiated thyroid cancers. Finally, there is medullary thyroid cancer, a neuroendocrine tumour of parafollicular c cell origin that just happens to occur in the thyroid gland but is not of thyroid cell origin. We now understand quite a lot about the molecular pathways involved in the development of thyroid cancers and this has helped to classify variants of these tumours and also helped to identify therapeutic strategies in cancers that are beyond surgical treatment. The mainstay of treatment of thyroid cancer however, remains  surgery and the vast majority of thyroid cancers are cured with this and sometimes the use of I131.

Differentiated Thyroid Cancer

Papillary Thyroid Cancer

Papillary thyroid cancer (PTC) is the most common thyroid malignancy making up 75-80% of all thyroid cancers. It occurs in woman 4 x more frequently than men and is predominantly a tumour of adulthood in the child bearing age group but it does occur in children. 67% present with a thyroid nodule, 13 % present with a nodule and lymph nodes and 20% present with lymph nodes alone. Lymph nodes can be small and can undergo cystic change and be mistaken for branchial cleft cysts. Occult micropapillary cancers occur in 6% of the population and are present at autopsy. There are a number of variants of PTC some of which have behaviour similar to or better than classic variant PTC like Follicular Variant , Encapsulated Variant, Cribriform-morular variant and Diffuse Sclerosing variant. Some have worse behaviour and generally occur in older patients such as Tall Cell Variant, Columnar Cell Variant, Hobnail Cell Variant and Solid and Trabecular Variant PTC.

Follicular Thyroid Cancer

Follicular thyroid cancer (FTC) is the next most common making up 6-10% of all thyroid cancers. 75% occur in women and age incidence peaks at 40-60 years. Iodine deficiency and radiation exposure are risk factors. Most present with a thyroid nodule and lymph node involvement is uncommon but up to 69% develop distant metastases to lung and bone . There are 3 main types of FTC: Minimally Invasive FTC with a very good long term prognosis, Encaspulated Angioinvasive FTC which does worse and Widely Invasive FTC with a high distant metastatic rate and 50% longterm mortality.

Hurthle Cell Thyroid Cancer

A follicular tumour with >75% oncocytic cells. The oncocytic (Hurthle) cells are due to being packed with abnormal mitochondria. These tumours are most common in older men ( mean age 57yrs). Hurthle cell cancers are more aggressive than follicular cancers with more extrathyroid extension, more metastases to lymph nodes and higher rates of mortality ( up to 80%)

Poorly Differentiated Thyroid Cancer

This is a malignancy of Follicular cell origin that makes up 0.3-7% of all thyroid cancers. It occurs in older patients and presents as a large solid thyroid mass. There is a high rate of nodal and haematogenous metastases and a 3 yr survival rate of around 35%. It has behaviour that sits between differentiated thyroid cancer and anaplastic cancer and can originate de novo or from a differentiated thyroid cancer or goitre and can under go a series of mutations to de-differentiate. There are insular, solid and trabecular variants and these cell pattern types can be mixed. Tumours must also demonstrate tumour necrosis, a high mitotic rate and or convoluted nuclei.

Medullary Thyroid Cancer

A neuroendocrine tumor derived from C cells  of the ultimobranchial body of the neural crest, which secrete calcitonin. Makes up  1 – 2% of thyroid carcinomas. 70% are  sporadic (nonhereditary) and 30% familial (hereditary). The sporadic tumours are solitary and peak in ages 40 – 60. The hereditary type occurs in  younger patients (mean age 35) and are usually bilateral and  multicentric with C cell hyperplasia. Familial MTC is due to MEN 2A or 2B syndromes, familial medullary thyroid carcinoma (FMTC) syndrome, von Hippel-Lindau disease or neurofibromatosis. This is caused by gain of function germline mutations in the RET gene. Presents as a hard thyroid mass and up to 75% have nodal metastases. Serum calcitonin correlates with tumour burden and those with systemic metastases may have diarrhoea and flushing. 5 year survival is 65-90% and prognosis is worse with higher stage, nodal metastases, male, MEN2B, 918RET mutation, high mitotic activity and vascular invasion.


Anaplastic Thyroid Cancer

Anaplastic thyroid cancer (ATC) is among the most aggressive and deadly human cancers. It makes up 2-5% of thyroid cancers but is responsible for 40% of thyroid cancer deaths. This tumour presents as a rapidly progressive large neck mass with invasion of central compartment structures associated symptoms of hoarseness, dyspnoea and dysphagia. There are usually involved lymph nodes and 30-40% present with distant metastases. 50% have a prior multi nodular goitre and 20% have a prior differentiated thyroid cancer. 20% have a concurrent differentiated thyroid cancer and dedifferentiation occurs in this tumour with a high rate of TP53 mutation. 1 year survival is in the 10-20% range.


Thyroid cancer warning signs.

1. Thyroid nodule:

The most common presentation of thyroid cancer is a nodule in the thyroid gland. Cancerous nodules tend to be harder, more fixed, larger  and more irregular than non cancerous nodules.

thyroid ultrasound showing right thyroid cancer

thyroid ultrasound showing right thyroid cancer

Thyroid cancer is also highly likely in a patient who has a thyroid nodule and has:

2. Lymph nodes:

Thyroid cancer lymph nodes are frequently cystic and can often appear lower in the neck than metastases from other head and neck primary sites. The nodes are usually large, round and have loss of the normal architecture. The appearance on ultrasound often mimics the appearance of the primary thyroid cancer and punctate echogenic foci (PEF) appearing as small bright flecks can often be seen.

metastatic left level 2 neck lymph node

metastatic left level 2 neck lymph node

3. Hoarse Voice:

Less commonly thyroid cancer can invade surrounding structures and the most common structure is the recurrent laryngeal nerve that supplies muscles of the voice box. This can lead to a breathy and hoarse voice.

4. Haemoptysis (coughing up blood):

The trachea (windpipe) is next most commonly involved and invasion of this can lead to bleeding

5. Stridor (noisy breathing) and shortness of breath:

Also caused by tracheal invasion

6. Dysphagia (difficulty swallowing):

Invasion of the oesophagus can lead to increasing difficulty swallowing. This is relatively uncommon and usually the muscle of the oesophagus is involved and not the mucosal lining

7. Family history of thyroid cancer:

A patient with a strong family history of thyroid cancer and a nodule has a higher risk of thyroid cancer. Particularly in medullary thyroid cancer. This is far less of an issue in papillary thyroid cancer unless there are 3 first degree relatives in a family with the diagnosis

8. History of radiation to neck:

A patient with a thyroid nodule and a history of previous therapeutic or environmental radiation exposure particularly in childhood is at much higher risk of having thyroid cancer. Populations who live in iodine deficient areas and around volcanoes are also at much higher risk of thyroid cancers.

9. Ultrasound risk features:

A thyroid nodule that is solid, hypoechoic ( darker on ultrasound), an irregular margin, taller than wide in shape and has multiple punctate echogenic foci is high risk for being a thyroid cancer. These features are used in scoring systems that are used as risk assessment tools for thyroid nodules to determine which should be biopsied or observed and which can be ignored. One such system in common use in Auckland is the TIRADS system.

Thyroid nodule in left upper pole: Hypoechoic, solid, taller than wide and irregular margin with punctate echogenic foci. TIRADS TR5

Thyroid nodule in left upper pole: Hypoechoic, solid, taller than wide and irregular margin with punctate echogenic foci. TIRADS TR5

10. Diarrhoea: 

Patients with a thyroid nodule and persistent diarrhoea may have medullary thyroid cancer with an elevated calcitonin level that leads to the diarrhoea. These patient will also usually have an elevated CEA level which is a non specific marker for cancer.


Any patients with these features should be referred early for assessment with Examination, laryngeal endoscopy, ultrasound and FNA biopsy all available in one stop in Dr Chaplin’s practice at Mauranui Clinic

John has just returned from the ASOHNS ASM in Brisbane where he was involved as an invited speaker. John spoke in a plenary session on the use of energy devices in thyroid surgery. The talk included a review of a personal series of thyroidectomies. John has performed over 50 thyroidectomy procedures per year since 2002 and over 100 per year  since 2004 with a total number of over 1800. John then presented some complex thyroid cancer cases to a panel of experts. The meeting was a great success with over 500 registrants and a high quality program.

Dr John Chaplin is currently returning from Kaohsiung Taiwan where he attended the 3rd meeting of the APTS. The meeting was was supported by the Taiwanese Head and Neck Cancer Surgery Society. There were over 700 participants from all over the world and John presented an invited lecture on the use of Harmonic scalpel in thyroid surgery. The talks covered all aspects of thyroid cancer, thyroid nodules, goitre  surgery and included multidisciplinary management of locally advanced, poorly differentiated and anaplastic thyroid cancer and also  management of papillary micro carcinoma. It was culturally interesting with surgeons and specialists from a diverse range of regional and international nations in attendance. The APTS is now affiliated with the American  Head and Neck Surgery Society (AHNS) Endocrine Surgery Group and this has given great endorsement to the APTS.

Dr John Chaplin helped convene a thyroid cancer workshop at Auckland City Hospital on 22 Nov this year. Dr Bryan McIver, Endocrine Oncologist, from Moffitt Cancer Center in Tampa, Florida USA was guest speaker. The meeting was attended by thyroid surgeons and endocrinologists from around the North Island. The first part of the meeting involved case presentations to Dr McIver who discussed the various scenarios and the treatment recommendations based on the latest ATA guidelines with input and questions from the audience. Dr McIver then spoke on risk assessment of thyroid cancer, the use of radio iodine in differentiated thyroid cancer and poorly differentiated and anaplastic thyroid cancer. There were also talks on thyroid surgery, bleeding, IONM, vocal fold rehabilitation and  medullary thyroid cancer. An academic dinner followed the meeting where Dr McIver then spoke on assessment of thyroid nodules particularly with respect to Molecular testing of FNA biopsy samples. He attended the thyroid cancer endocrine MDM on Friday where further thyroid malignancy case discussions were followed by a talk on the use of external beam radiation therapy in thyroid cancer.

Thyroid Cancer One Day Meeting

 Wed 21st November 2018

Clinical Education Centre

Level 5

Auckland City Hospital

Academic programme

 Morning session  – Thyroid Cancer MDM   8am – 12.45pm

0800  registration/ meet & greet

 0815        Multidisciplinary Case discussions with Dr Bryan McIver

10.15       Morning tea

10.45       Multidisciplinary Case discussions with Dr Bryan McIver

12.45 -1.15  lunch

 Afternoon session  – Scientific Programme   1.15pm -17.30pm

 13.15       Prevalence of thyroid cancer in NZ              Dr Geoff Braatvedt

13.30     Risk stratification of thyroid nodules

– with audience polling                                 Dr Bruno Carvalho

14.00       Shorter operative times, less bleeding           Dr John Chaplin

14.15       Avoiding hypoparathyroidism                           Dr Nick McIvor

14.30       Nerve monitoring                                             Dr John Chaplin     

14.45       Risk stratification for recurrence… ?RAI         Dr Bryan McIver


15.15       Afternoon tea


15.45       Management of laryngeal nerve injury             Dr David Vokes

16.00       Management of RAI-refractory thyroid ca Dr Bryan McIver

16.30       Anaplastic carcinoma                                             Dr Nick McIvor

16.45       Management of Medullary Thyroid Cancer in NZ   Dr Joey Siu


17.00       General discussion with comments by Dr Bryan McIver

17.30       Close


Book your appointment